AMGN
Amgen Inc
414.60$
+2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.7% | -9.1% | +12.6% | +1.4% | +6.9% | -10.3% | +12.5% | +4.3% | +3.5% | -12.9% | +16.7% | – | |
| – | +72.3% | +2.8% | +1.1% | +2.3% | -6.0% | -4.6% | +1.4% | +2.4% | -41.9% | +53.3% | +2.4% | – | |
| – | -0.3% | -16.5% | +21.3% | +0.8% | +15.0% | -13.3% | +18.8% | +5.2% | +25.2% | -27.5% | +23.3% | – | |
| – | +42.2% | -12.5% | +7.7% | +0.2% | +18.9% | -13.8% | +17.4% | +8.9% | +13.2% | -20.1% | +8.7% | – | |
| – | +20.3% | +11.1% | -1.3% | -9.0% | -45.2% | +89.3% | +0.2% | +1.7% | +13.5% | -17.9% | +8.9% | – | |
| – | +24.0% | -14.6% | -0.4% | -3.0% | +16.4% | +9.3% | -12.3% | +12.4% | +5.4% | -23.0% | +16.2% | – | |
| – | -37.1% | -22.0% | +92.6% | +7.2% | +12.9% | -49.0% | +124.4% | -4.5% | +56.1% | -32.4% | +31.8% | – | |
| – | +8.2% | +0.4% | -1.9% | -4.0% | -3.7% | -3.2% | -2.1% | -3.2% | -4.7% | +0.6% | +2.4% | – | |
| – | -56.2% | -108.0% | – | +290.6% | -74.8% | +152.3% | -20.5% | +150.1% | -61.4% | +37.6% | +32.8% | – | |
| – | -60.8% | -47.1% | +6.7% | +464.6% | -42.8% | +56.8% | -44.0% | +418.4% | -74.3% | +46.4% | +48.3% | – | |
| – | -55.7% | -114.7% | – | +279.4% | -77.8% | +175.9% | -17.2% | +124.6% | -58.6% | +36.5% | +30.6% | – | |
| – | -15.2% | -29.4% | +39.3% | +75.6% | -44.5% | +39.5% | -11.4% | +63.5% | -44.2% | +16.9% | -10.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.